3.99
price down icon1.23%   -0.08
 
loading
Schlusskurs vom Vortag:
$4.07
Offen:
$3.97
24-Stunden-Volumen:
278.84K
Relative Volume:
0.24
Marktkapitalisierung:
$143.79M
Einnahmen:
$59.63M
Nettoeinkommen (Verlust:
$-72.21M
KGV:
-1.90
EPS:
-2.1
Netto-Cashflow:
$-30.85M
1W Leistung:
-0.74%
1M Leistung:
+79.46%
6M Leistung:
+18.58%
1J Leistung:
-39.18%
1-Tages-Spanne:
Value
$3.90
$4.16
1-Wochen-Bereich:
Value
$3.85
$4.57
52-Wochen-Spanne:
Value
$1.81
$7.4802

908 Devices Inc Stock (MASS) Company Profile

Name
Firmenname
908 Devices Inc
Name
Telefon
978-729-4478
Name
Adresse
645 SUMMER STREET, BOSTON
Name
Mitarbeiter
246
Name
Twitter
Name
Nächster Verdiensttermin
2024-12-12
Name
Neueste SEC-Einreichungen
Name
MASS's Discussions on Twitter

Vergleichen Sie MASS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
MASS
908 Devices Inc
4.00 143.79M 59.63M -72.21M -30.85M -2.10
Medical Devices icon
ABT
Abbott Laboratories
131.70 225.32B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
100.76 149.74B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
375.31 142.48B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
88.69 113.49B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
72.11 42.10B 5.72B 4.17B 259.90M 6.97

908 Devices Inc Stock (MASS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-11-13 Herabstufung Leerink Partners Outperform → Market Perform
2023-02-07 Eingeleitet Stephens Overweight
2021-10-15 Fortgesetzt Cowen Outperform
2021-01-12 Eingeleitet Cowen Outperform
2021-01-12 Eingeleitet SVB Leerink Outperform
2021-01-12 Eingeleitet Stifel Buy
2021-01-12 Eingeleitet William Blair Outperform
Alle ansehen

908 Devices Inc Aktie (MASS) Neueste Nachrichten

pulisher
Apr 01, 2025

Charles Schwab Investment Management Inc. Has $444,000 Stake in 908 Devices Inc. (NASDAQ:MASS) - Defense World

Apr 01, 2025
pulisher
Mar 24, 2025

908 Devices (NASDAQ:MASS) Given Sell (E+) Rating at Weiss Ratings - Defense World

Mar 24, 2025
pulisher
Mar 14, 2025

Q1 Earnings Estimate for 908 Devices Issued By William Blair - Defense World

Mar 14, 2025
pulisher
Mar 12, 2025

908 Devices (MASS) Stock Jumps on Strength of New Order Announcement - Stocks Telegraph

Mar 12, 2025
pulisher
Mar 11, 2025

908 Devices gets $1.7M order from Ministry of Health of Ukraine - MSN

Mar 11, 2025
pulisher
Mar 11, 2025

908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device - 01net

Mar 11, 2025
pulisher
Mar 11, 2025

908 Devices climbs on $1.7 mln order from Ukraine - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

908 Devices secures $1.7 million order from Ukraine - Investing.com India

Mar 11, 2025
pulisher
Mar 11, 2025

908 Devices secures $1.7 million order from Ukraine By Investing.com - Investing.com South Africa

Mar 11, 2025
pulisher
Mar 11, 2025

908 Devices Receives $1.7M Order From The Ministry Of Health Of Ukraine For Its Handheld Mass Spec Device - Marketscreener.com

Mar 11, 2025
pulisher
Mar 11, 2025

Major Win: Ukraine Orders $1.7M of 908 Devices' Advanced Threat Detection Tech - StockTitan

Mar 11, 2025
pulisher
Mar 10, 2025

What Is The Outlook For 908 Devices Inc (NASDAQ: MASS) Like For Short-Term? - Stocks Register

Mar 10, 2025
pulisher
Mar 10, 2025

908 Devices: Strategic Divestiture and Strong Financial Performance Drive Buy Rating - TipRanks

Mar 10, 2025
pulisher
Mar 09, 2025

Repligen Corporation’s Acquisition of Bioprocessing PAT Device Portfolio from 908 Devices - Global Legal Chronicle

Mar 09, 2025
pulisher
Mar 08, 2025

Weiss Ratings Reaffirms Sell (E+) Rating for 908 Devices (NASDAQ:MASS) - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates - MSN

Mar 08, 2025
pulisher
Mar 07, 2025

908 Devices Inc. SEC 10-K Report - TradingView

Mar 07, 2025
pulisher
Mar 06, 2025

Repligen buying 908 Devices’ Bioprocess Analytics portfolio - BioWorld Online

Mar 06, 2025
pulisher
Mar 06, 2025

908 Devices Makes Key Divestiture (Rating Upgrade) (NASDAQ:MASS) - Seeking Alpha

Mar 06, 2025
pulisher
Mar 06, 2025

908 Devices earnings missed by $0.33, revenue fell short of estimates - Investing.com Australia

Mar 06, 2025
pulisher
Mar 05, 2025

Stifel maintains Buy on 908 Devices, target steady at $6 By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 05, 2025

Stifel maintains Buy on 908 Devices, target steady at $6 - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

908 Devices Inc. Reports Strategic Transformation and Growth - MSN

Mar 05, 2025
pulisher
Mar 05, 2025

Repligen lays down $70m to buy analytics tech from 908 Devices - BioProcess Insider

Mar 05, 2025
pulisher
Mar 05, 2025

Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices - Genetic Engineering & Biotechnology News

Mar 05, 2025
pulisher
Mar 05, 2025

908 Devices Inc.'s (NASDAQ:MASS) 55% Jump Shows Its Popularity With Investors - Simply Wall St

Mar 05, 2025
pulisher
Mar 05, 2025

908 Devices Inc (MASS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ... - Yahoo Finance

Mar 05, 2025
pulisher
Mar 04, 2025

908 Devices stock surges on strategic transformation and growth outlook By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

908 Devices stock surges on strategic transformation and growth outlook - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

Repligen Corporation acquired the assets related to bioprocessing analytics portfolio of 908 Devices Inc. for $56 million. - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

908 Devices jumps as Repligen buys bioprocessing analytics portfolio - MSN

Mar 04, 2025
pulisher
Mar 04, 2025

Earnings call transcript: 908 Devices Q4 2024 revenue up 31%, stock surges - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

MASS’s 2023 Market Dance: Up 66.78% – Time to Invest? - The InvestChronicle

Mar 04, 2025
pulisher
Mar 04, 2025

908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth - Benzinga India

Mar 04, 2025
pulisher
Mar 04, 2025

Strategic Divestment and Focus on Growth Propel 908 Devices to a Buy Rating - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

908 Devices reports Q4 EPS (56c), consensus (35c) - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

908 Devices Inc. reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 04, 2025
pulisher
Mar 04, 2025

Repligen Corporation acquired Bioprocessing Analytics Portfolio from 908 Devices Inc. for $70 million. - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Repligen’s Strategic Acquisition of 908 Devices’ Bioprocessing Assets Boosts Buy Rating - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

MASSive Gains for 908 Devices: Is This Stock Turning Around? - RagingBull

Mar 04, 2025
pulisher
Mar 04, 2025

908 Devices Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Investor presentation (03/04/2025 00: 00 - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Repligen Acquires 908 Devices’ Bioprocess Analytics Portfolio - Contract Pharma

Mar 04, 2025
pulisher
Mar 04, 2025

908 DEVICES Earnings Results: $MASS Reports Quarterly Earnings - Nasdaq

Mar 04, 2025
pulisher
Mar 04, 2025

908 Devices stock jumps on Repligen deal (RGEN:NASDAQ) - Seeking Alpha

Mar 04, 2025
pulisher
Mar 04, 2025

908 Devices sells desktop assets, sees revenue growth - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

908 Devices stock soars on divestiture and revenue growth By Investing.com - Investing.com Canada

Mar 04, 2025
pulisher
Mar 04, 2025

Repligen acquires 908 Devices’ desktop bioprocessing tech By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

908 Devices stock soars on divestiture and revenue growth - Investing.com

Mar 04, 2025

Finanzdaten der 908 Devices Inc-Aktie (MASS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

908 Devices Inc-Aktie (MASS) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Turner Michael S.
Chief Legal & Admin Officer
Feb 03 '25
Sale
2.33
9,672
22,499
24,603
Knopp Kevin J.
President and CEO
Feb 03 '25
Sale
2.32
16,001
37,109
692,733
Brown Christopher D.
Chief Product Officer
Feb 03 '25
Sale
2.34
7,767
18,191
962,122
Brown Christopher D.
Chief Product Officer
Dec 19 '24
Option Exercise
1.58
55,131
87,107
946,453
Knopp Kevin J.
President and CEO
Dec 13 '24
Option Exercise
1.63
158,044
257,771
667,025
Brown Christopher D.
Chief Product Officer
Aug 07 '24
Option Exercise
1.58
6,328
9,998
891,322
Eisenberg Marcia
Director
Jun 07 '24
Option Exercise
0.00
682
0
6,816
Knopp Kevin J.
President and CEO
May 13 '24
Buy
6.42
10,000
64,200
508,981
Knopp Kevin J.
President and CEO
May 10 '24
Buy
5.77
10,000
57,700
498,981
Knopp Kevin J.
President and CEO
May 09 '24
Buy
5.83
10,000
58,300
488,981
medical_devices STE
$227.62
price up icon 0.80%
medical_devices ZBH
$112.47
price up icon 0.09%
medical_devices PHG
$24.92
price down icon 1.17%
$67.12
price down icon 0.77%
$79.03
price down icon 0.72%
medical_devices EW
$72.21
price up icon 0.49%
Kapitalisierung:     |  Volumen (24h):